ArticleViruses2023

Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity.

Etsuhisa Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.